We are live on ! Find out more
ACM

Athyrium Capital Management Portfolio holdings

AUM $8.69M
1-Year Est. Return 34.58%
This Fund
S&P 500
This Quarter Est. Return
-15.52%
1 Year Est. Return
-34.58%
3 Year Est. Return
-25.1%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$240M
AUM Growth
+$42.1M
Cap. Flow
+$80M
Cap. Flow %
33.33%
Top 10 Hldgs %
100%
Holding
4
New
1
Increased
1
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
CMAX
CareMax, Inc. Class A Common Stock
CMAX
+$51.3M
2
BIOR
Biora Therapeutics, Inc. Common Stock
BIOR
+$28.6M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BIOR
1
DELISTED
Biora Therapeutics, Inc. Common Stock
BIOR
$130M 54.17%
145,588
+37,461
+35% +$28.6M
AMYT
2
DELISTED
Amryt Pharma plc American Depositary Shares
AMYT
$54.8M 22.86%
4,520,000
– –
CMAX
3
DELISTED
CareMax, Inc. Class A Common Stock
CMAX
$50M 20.85%
+129,219
New +$51.3M
SCTL
4
DELISTED
Societal CDMO, Inc. Common Stock
SCTL
$5.09M 2.12%
2,202,420
– –

Similar funds

BGC
Birch Grove Capital New York $9.51M AUM 0.22% 1-Year Est. Return
RVM
RiverVest Venture Management St. Louis, Missouri $6.84M AUM 7.71% 1-Year Est. Return
JDR
Jay D. Rosenbaum $6.69M AUM 4.68% 1-Year Est. Return
DA
DSC Advisors Chicago, Illinois $11M AUM 5.88% 1-Year Est. Return
KIM
Kaizen Investment Management Singapore $6.23M AUM
RJTCONH
Raymond James Trust Company of New Hampshire Portsmouth, New Hampshire $12.1M AUM 28.84% 1-Year Est. Return
HSC
Harbor Spring Capital New York $12.3M AUM
HVM
Harvest Volatility Management Norwalk, Connecticut $4.39M AUM 13.08% 1-Year Est. Return

Athyrium Capital Management's Q2 2021 Portfolio in Review

As of Q2 2021, Athyrium Capital Management held 4 positions worth $240M, up 21% from $198M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Athyrium Capital Management deployed $80M of net new capital in Q2 2021, opening 1 new position and adding to 1 existing holding. Its largest new stake was CareMax, Inc. Class A Common Stock: 129,219 shares worth $50M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Athyrium Capital Management's largest Q2 2021 buy was CareMax, Inc. Class A Common Stock: 129,219 shares worth $50M.
  • Athyrium Capital Management added most to Biora Therapeutics, Inc. Common Stock in Q2 2021, an estimated $28.6M increase.
  • Athyrium Capital Management's ten largest holdings make up 100% of its $240M portfolio in Q2 2021.
  • Athyrium Capital Management opened 1 new position and closed 0 in Q2 2021.
  • Athyrium Capital Management's portfolio value rose 21% quarter-over-quarter to $240M.

Based on Athyrium Capital Management's 13F filing for Q2 2021, filed 16 Aug 2021.